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A B S T R A C T
Hepatic fibrosis is caused by chronic inflammation and characterized as the excessive accumulation of extra-
cellular matrix (ECM) by activated hepatic stellate cells (HSCs). Gasotransmitters like NO and CO are known to
modulate inflammation and fibrosis, however, little is known about the role of the gasotransmitter hydrogen
sulfide (H2S) in liver fibrogenesis and stellate cell activation. Endogenous H2S is produced by the enzymes
cystathionine β-synthase (CBS), cystathionine γ-lyase (CTH) and 3-mercaptopyruvate sulfur transferase (MPST)
[1]. The aim of this study was to elucidate the role of endogenously produced and/or exogenously administered
H2S on rat hepatic stellate cell activation and fibrogenesis. Primary rat HSCs were culture-activated for 7 days
and treated with different H2S releasing donors (slow releasing donor GYY4137, fast releasing donor NaHS) or
inhibitors of the H2S producing enzymes CTH and CBS (DL-PAG, AOAA). The main message of our study is that
mRNA and protein expression level of H2S synthesizing enzymes are low in HSCs compared to hepatocytes and
Kupffer cells. However, H2S promotes hepatic stellate cell activation. This conclusion is based on the fact that
production of H2S and mRNA and protein expression of its producing enzyme CTH are increased during hepatic
stellate cell activation. Furthermore, exogenous H2S increased HSC proliferation while inhibitors of endogenous
H2S production reduce proliferation and fibrotic makers of HSCs. The effect of H2S on stellate cell activation
correlated with increased cellular bioenergetics. Our results indicate that the H2S generation in hepatic stellate
cells is a target for anti-fibrotic intervention and that systemic interventions with H2S should take into account
cell-specific effects of H2S.
1. Introduction
Chronic inflammation occurs in many liver diseases, e.g. non-alco-
holic steatohepatitis (NASH), viral infection or chronic alcohol con-
sumption. Liver fibrosis can be viewed as an uncontrolled wound
healing response. Hepatic stellate cells (HSCs) play an important role in
the onset and perpetuation of liver fibrosis. Under normal conditions,
HSCs are quiescent and are the principal vitamin A storing cells in the
liver [1]. In conditions of chronic inflammatory liver injury, quiescent
hepatic stellate cells (qHSCs) transform into proliferative myofibro-
blast-like cells called activated HSCs (aHSCs). During activation, HSCs
lose their vitamin A content and start to produce large amounts of ex-
tracellular matrix (ECM) [2]. When the inflammatory response is not
suppressed, the excessive accumulation of ECM can lead to hepatic fi-
brosis, cirrhosis and eventually hepatocellular carcinoma. At present,
there is no effective treatment for hepatic fibrosis, leaving liver trans-
plantation as the only viable treatment option. Therefore, it is im-
portant to understand the mechanisms that lead to hepatic stellate cell
activation and hepatic fibrosis [3,4]. Gasotransmitters like nitric oxide
(NO) and carbon monoxide (CO) have been shown to play an important
role in chronic liver inflammation and liver fibrosis [5,6]. Recently,
interest has been focused on another gasotransmitter, hydrogen sulfide
(H2S) [7–9].
In the last two decades, H2S has been identified as a gasotransmitter
that is generated in many mammalian cells and is involved in various
physiological and pathophysiological processes as a signaling molecule
similar to NO and CO [10]. H2S has also been implicated to modulate
inflammation and fibrosis, although its role in liver fibrosis and hepatic
stellate cell activation is still not completely elucidated.
H2S is produced intracellularly from cysteine and methionine by the
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enzymes cystathionine β-synthase (CBS), cystathionine γ-lyase (CTH)
and 3-mercaptopyruvate sulfur transferase (MPST) [11,12]. It has been
shown to regulate hepatic fibrosis via its anti-oxidative and anti-in-
flammatory properties and by inducing cell-cycle arrest, apoptosis,
vasodilation and reduction of portal hypertension [8,9,13–16]. How-
ever, most of these experiments were performed in vivo conditions and
did not focus directly on the process of fibrogenesis and HSCs activa-
tion. Furthermore, conflicting results have been reported depending on
the concentration or type of H2S donor used. Based on the H2S release
rate, H2S releasing donors can be categorized as fast (NaHS; Na2S) or
slow (GYY4137; ADT-OH) releasing donors, often yielding contrasting
results [17–19]. For instance, some studies reported pro-inflammatory
and anti-apoptotic properties of H2S and in some studies H2S was
shown to increase mitochondrial bioenergetics and promote cell pro-
liferation [20–23]. Therefore, there are still major gaps in our under-
standing of the actual effects of H2S on HSCs and liver fibrosis.
The aim of the current study was to elucidate the effects of H2S on
HSCs by investigating how endogenously produced and/or exogenously
administered H2S affects primary rat HSCs and its proliferation.
Furthermore, we tried to elucidate the dynamics of endogenous pro-
duction of H2S and H2S synthesizing enzymes during HSCs activation.
2. Materials and methods
2.1. Hepatic stellate cell isolation and culture
Specified pathogen-free male Wistar rats were purchased from
Charles River (Wilmington, MA, USA) and housed in a 12hr light-dark
cycle under standard animal housing conditions with free access to
chow and water. HSCs were isolated from rats weighing 350–450 g,
anesthetized by isoflurane and a mixture of Ketamine and
Medetomidine. The liver was perfused via the portal vein with a buffer
containing Pronase-E (Merck, Amsterdam, the Netherlands) and
Collagenase-P (Roche, Almere, the Netherlands). The HSC population
was isolated by density centrifugation using 13% Nycodenz (Axis-
Shield POC, Oslo, Norway) solution. Isolated HSCs were cultured in
Iscove's Modified Dulbecco's Medium supplemented with Glutamax
(Thermo Fisher Scientific, Waltham, MA, USA), 20% heat inactivated
fetal calf serum (Thermo Fisher Scientific), 1% MEM Non Essential
Amino Acids (Thermo Fisher Scientific), 1% Sodium Pyruvate (Thermo
Fisher Scientific, Waltham, MA, USA) and antibiotics: 50 μg/mL gen-
tamycin (Thermo Fisher Scientific), 100 U/mL Penicillin (Lonza,
Vervier, Belgium), 10 μg/mL streptomycin (Lonza) and 250 ng/mL
Fungizone (Lonza) in an incubator containing 5% CO2 at a 37 °C [24].
Quiescent HSCs (day 1) spontaneously activate when cultured on tissue
culture plastic and reached complete activation (increased prolifera-
tion, loss of retinoids and increased synthesis of extracellular matrix
components) after 7 days of culture. Day 3 cultured HSCs are con-
sidered intermediately activated.
2.2. Experimental design
Culture-activated HSCs (aHSCs) were treated with H2S donors or
inhibitors for 72 h. All treatments with H2S donors and inhibitors were
performed in fresh medium containing 20% FCS and other supple-
ments. H2S releasing donors GYY4137 (kind gift from Prof. Matt
Whiteman, University of Exeter, United Kingdom) and NaHS (Sigma-
Aldrich, Zwijndrecht, the Netherlands) were diluted in distilled water
and prepared freshly. NaHS was added every 8 h to the cells because of
its rapid evaporation. The CBS inhibitor O-(carboxymethyl) hydro-
xylamine, AOAA (Sigma-Aldrich) was prepared as a 200mmol/L stock
solution and diluted in distilled water at neutral pH. CTH inhibitor DL-
propargylglycine, DL-PAG (Sigma-Aldrich) was freshly prepared.
2.3. Measurement of H2S concentration
The accumulation of H2S in the culture medium was measured as
described previously [25,26]. After 72 h incubation, medium samples
were collected in 250 μL of 1% (wt/vol) zinc acetate and distilled water
was added up to 500 μL. Next, 133 μl of 20mmol/L N-dimethyl-p-
Abbreviations
Akt protein kinase B
AOAA amino-oxyacetic acid
ATP adenosine triphosphate
BDL bile duct ligation
BrdU 5-bromo-2′-deoxyuridine
CBS cystathionine β-synthase
cDNA complementary deoxyribonucleic acid
CO carbon monoxide
CTH cystathionine γ-lyase
Col1α1 collagen type 1 alpha 1
DL-PAG dl-Propargylglycine
ECAR Extra-cellular acidification rate
ECM extracellular matrix
FCCP trifluoromethoxy carbonylcyanide phenylhydrazone
GAPDH glyceraldehyde 3-phosphate dehydrogenase
H2O2 hydrogen peroxide
HBSS Hanks' balanced salt solution
H2S hydrogen sulfide
HSCs hepatic stellate cells




mRNA messenger ribonucleic acid
OCR Oxygen consumption rate
p38 MAP-Kinase P38 mitogen-activated protein kinases
PDGF-BB platelet-derived growth factor BB
PLP Pyridoxal phosphate
TGFβ1 transforming growth factor beta 1
Table 1
Primer sequences.
Gene Sense 5′-3′ Antisense 5′-3′ Probe 5′-3′
18s CGGCTACCACATCCAAGGA CCAATTACAGGGCCTCGAAA CGCGCAAATTACCCACTCCCGA
Col1α1 TGGTGAACGTGGTGTACAAGGT CAGTATCACCCTTGGCACCAT TCCTGCTGGTCCCCGAGGAAACA
Acta2 GCCAGTCGCCATCAGGAAC CACACCAGAGCTGTGCTGTCTT CTTCACACATAGCTGGAGCAGCTTCTCGA
Cth TACTTCAGGAGGGTGGCATC AGCACCCAGAGCCAAAG no probe, qPCR with Sybr green
Cbs GCGGTGGTGGATAGGTGGTT CTTCACAGCCACGGCCATAG no probe, qPCR with Sybr green
Mpst TGGAACAGGCGTTGGATCTC GGCATCGAACCTGGACACAT no probe, qPCR with Sybr green
36b4 GCTTCATTGTGGGAGCAGACA CATGGTGTTCTTGCCCATCAG TCCAAGCAGATGCAGCAGATCCGC
Tgfβ1 GGG CTA CCA TGC CAA CTT CTG GAG GGC AAG GAC CTT GCT GTA CCT GCC CCT ACA TTT GGA GCC TGG A
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phenylenediamine sulfate in 7.2mmol/L hydrogen chloride and 133 μl
30 mmol/L ferric chloride in 1.2 mmol/L hydrogen chloride were
added. After incubation for 10min at room temperature, protein was
removed by adding 250 μL trichloroacetic acid and centrifugation at
14000g for 5min. Spectrophotometry was performed at 670 nm light
absorbance (BioTek Epoch2 microplate reader) in 96 well-plates. All
samples were assayed in duplicated. Concentrations were calculated
against a calibration curve of NaHS (5–400 μmol/L) in culture medium.
2.4. Quantitative real-time polymerase chain reaction
Hepatic stellate cell RNA was isolated using Tri-reagent (Sigma-
Aldrich) according to the manufacturer's protocol. RNA concentrations
were measured by Nano-Drop 2000c (Thermo Fisher Scientific,
Waltham, MA, USA) and 1.5 μg of RNA was used for reverse tran-
scription (Sigma-Aldrich). cDNA was diluted in RNAse-free water and
used for real-time polymerase chain reaction on the QuantStudio™ 3
system (Thermo Fisher Scientific). All samples were analyzed in du-
plicate using 18S and 36b4 as housekeeping genes. The mRNA levels of
Cth, Cbs, Mpst (Invitrogen) were quantified using SYBR Green (Applied
Biosystems), other genes were quantified by TaqMan probes and pri-
mers. Relative gene expression was calculated via the 2-?Ct method. The
primers and probes are shown in Table 1.
2.5. Cell toxicity determination by Sytox Green
Cell necrosis was measured by Sytox Green nucleic acid staining
(Invitrogen, the Netherlands) at a dilution of 1:40.000 in culture
medium or HBSS for 15min at a 37 °C. Necrotic cells have ruptured
plasma membranes, allowing entrance of non-permeable Sytox green
into the cells. Sytox green then binds to nucleic acids. Fluorescent nu-
clei were visualized at an excitation wavelength of 450–490 nm by a
Leica microscope. Hydrogen peroxide 1mmol/L was used as a positive
control.
2.6. Cell proliferation measurement
Proliferation of aHSCs was measured by Real-Time xCELLigence
system (RTCA DP; ACEA Biosciences, Inc., CA, USA) and by colori-
metric BrdU cell proliferation ELISA kit (Roche Diagnostic Almere, the
Netherlands). Cells were seeded in a 16-well E-plate and treated as
indicated. Cell index was determined by measuring the change of im-
pedance on the xCELLigence system.
For BrdU incorporation assay, aHSCs were seeded in a 96-well plate
and treated as indicated. BrdU incorporation was determined according
to manufacturer's instructions and quantified by light emission chemi-
luminiscence using the Synergy-4 machine (BioTek).
2.7. Western blot analysis
Cells were seeded in 6-well plates and treated as described. Protein
lysates were collected by scraping in cell lysis buffer (HEPES 25mmol/
L, KAc 150mmol/L, EDTA pH 8.0 2mmol/L, NP-40 0.1%, NaF
10mmol/L, PMSF 50mmol/L, aprotinin 1 μg/μL, pepstatin 1 μg/μL,
leupeptin 1 μg/μL, DTT 1mmol/L). Total amount of protein in lysates
was measured by Bio-Rad protein assay (Bio-Rad; Hercules, CA, USA).
For Western blotting, 20–30 μg protein was loaded on SDS-PAGE gels.
Proteins were transferred to nitrocellulose transfer membranes using
Trans-Blot Turbo Blotting System for tank blotting. Proteins were de-
tected using the following primary antibodies: monoclonal mouse anti-
GAPDH 1:5000 (CB1001, Calbiochem), polyclonal goat anti-COL1α1
(1310-01, Southern Biotech), monoclonal mouse anti-ACTA2 1:5000
(A5228, Sigma Aldrich), polyconal rabbit anti-CTH 1:1000 (12217-1-
AP, Proteintech), monoclonal mouse anti-CBS 1:1000 (sc-271886, Santa
Cruz), monoclonal mouse anti-MPST 1:1000 (sc-374326, Santa Cruz).
Protein band intensities were determined and detected using the
Chemidoc MR (Bio-Rad) system.
Fig. 1. Expression of H2S producing enzymes and H2S production in hepatic stellate cells.
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2.8. Cellular bioenergetics analysis
Mitochondrial activity and production of ATP was assessed by XF24
Extracellular Flux Analyzer (Seahorse Bioscience, Agilent Technologies,
Santa Clara SA, USA). aHSCs were seeded in Seahorse XF24 cell culture
plates and treated as indicated for 48hrs. Oxygen Consumption Rate
(OCR) and Extra-Cellular Acidification Rate (ECAR) were assessed after
the addition of glucose (5mmol/L), oligomycin (1 μmol/L), FCCP
(0,25 μmol/L) and a mixture of antimycin (1 μmol/L), rotenone
(1 μmol/L), 2-Deoxy-D-glucose (100mmol/L). Results were normalized
for the protein concentration of each sample.
2.9. Bile duct ligation
Male Wistar rats were anaesthetized with halothane/O2/N2O and
subjected to bile duct ligation (BDL) as described by Kountouras J et al.
[27]. At the indicated times after bile duct ligation (BDL), the rats
(n=4 per group) were sacrificed, livers were perfused with saline and
removed. Control rats received a sham operation (SHAM). Specimens of
these livers were snap-frozen in liquid nitrogen for isolation of mRNA
and protein.
2.10. Statistical analysis
Results are presented as mean ± standard deviation (mean ± SD).
Every experiment was repeated at least 3 times. Statistical significance
was analyzed by Mann-Whitney test between the two groups and
Kruskal-Wallis followed by post-hoc Dunn's test for multiple compar-
ison test. Statistical analysis was performed with GraphPad Prism 7
(GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Hydrogen sulfide production is increased upon activation of hepatic
stellate cells
In order to determine the dynamics of H2S production and H2S
producing enzymes during HSC activation, mRNA expression of H2S
synthesizing enzymes was measured in quiescent (q) and activated (a)
HSCs and compared to the expression of these enzymes in hepatocytes
and Kupffer cells. As shown in Fig. 1, the H2S producing enzymes Cth,
Cbs and Mpst were expressed at low levels in qHSCs compared to he-
patocytes and Kupffer cells. Upon activation, Cth gene expression in-
creased in HSCs (Fig. 1A) while Cbs and Mpst mRNA levels were not
changed (Fig. 1B and C). In line with this, the accumulation of H2S in
culture medium was increased during HSC activation. In Fig. 1D, values
are normalized for cell number since the morphology and proliferation
rate of quiescent and activated stellate cells are very different (Fig. 1D).
Western blotting results showed similar trend as observed for the mRNA
expression data. Protein expression of CTH was increased during HSCs
activation (Fig. 1E).
Cth, Cbs and Mpst mRNA expression was determined in HSCs at day
1, 3, and 7 and compared to primary rat hepatocytes and Kupffer cells
(A-C). The cytosolic enzymes Cth and Cbs were abundantly expressed in
hepatocytes, while their expression was relatively low in HSCs. Upon
HSCs activation, Cth expression was induced 7-fold, and Mpst slightly
upregulated, whereas expression of Cbs was downregulated. Expression
levels are relative to 18S expression. D. Production of H2S in activated
and quiescent HSCs. The production of H2S was increased upon acti-
vation of HSCs. Results were normalized with respect to the number of
cells. E. Protein expressions of CTH, CBS, MPST of HSCs at different
time point and hepatocytes and Kupffer cells. Equal protein loading was
confirmed by Ponceau S staining and Western blot for GAPDH.
3.2. Effect of H2S on activation markers in hepatic stellate cells
In order to avoid confounding effects of cell toxicity, we optimized
the concentration of H2S donors and inhibitors by Sytox green staining.
At concentrations twice as high as used in the experiments, none of the
donors or inhibitors were toxic to HSCs (Fig. 2).
Toxicity of the compounds was checked by Sytox Green staining.
Hydrogen peroxide (1mmol/L; 6 h exposure) was used as a positive
control. The compounds DL-PAG (Cth inhibitor), AOAA (Cbs inhibitor),
GYY4137 (slow releasing donor) and NaHS (fast releasing donor) were
not toxic for HSCs. Duration of the treatment was 24hrs.
We next evaluated the effect of H2S on activation markers in aHSCs.
Inhibitors of H2S producing enzymes (DL-PAG, AOAA) decreased the
expression of the fibrogenic markers Col1α1 and Acta2 (Fig. 3A). The
Fig. 2. H2S releasing donors and enzyme inhibitors are not toxic for hepatic stellate cells.
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H2S donors GYY4137 and NaHS did not affect the expression of Col1α1.
However, GYY4137 slightly, but significantly, reduced Acta2 mRNA
expression (Fig. 3B). Interestingly, both of the two enzyme inhibitors
also downregulated the expression of Cth mRNA. The changes in mRNA
expression were reflected in similar changes in protein expression of
COL1α1 but not ACTA2 (Fig. 3C). Accumulation of H2S in culture
medium was reduced by inhibitors, whereas GYY4137 increased H2S
accumulation. Because of the fast release, no accumulation of H2S was
measured in NaHS-treated group. In Fig. 3D, we did not normalize
values to the number of cells (in contrast to Fig. 1), because experi-
ments were performed with only activated stellate cells over a limited
time span, in which it can be assumed that cell numbers will not differ
significantly (Fig. 3D).
The H2S synthesizing enzyme inhibitors DL-PAG and AOAA down-
regulated Col1α1, Acta2 and Cth mRNA expression while the H2S do-
nors GYY4137 and NaHS did not affect Cth and Col1α1 mRNA
expression (A, B). In contrast, GYY4137, but not NaHS reduced Acta2
mRNA expression slightly. 18S was used as a housekeeping gene. The
inhibitors also reduced COL1α1 protein level but not ACTA2 protein
level (C). GAPDH was used as loading control for protein analysis. The
accumulation over 72 h of H2S in culture medium was measured in the
experimental groups (D). DL-PAG and AOAA significantly reduced the
accumulation of H2S. Because of its fast release, no accumulation of H2S
was measured in the NaHS-treated group. Accumulation of H2S was
detected with the slow releasing donor GYY4137.
3.3. H2S promotes hepatic stellate cell proliferation
The effect of H2S on rat HSC proliferation was assessed using real-
time cell analyzing xCelligence and BrdU incorporation ELISA assays.
H2S donors promote, whereas H2S synthesizing enzyme inhibitors in-
hibit aHSCs proliferation, indicating a stimulatory effect of H2S on HSC
Fig. 3. mRNA and protein expression of HSC activation markers in response to H2S donors and enzyme inhibitors.
Fig. 4. H2S promotes the proliferation of activated hepatic stellate cells.
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proliferation (Fig. 4).
Culture-activated HSCs were treated with H2S donors and enzyme
inhibitors over period of 72 h. Cell proliferation was monitored by real-
time xCELLigence system (A) and confirmed with BrdU incorporation
ELISA assay (B). Inhibition of endogenous production of H2S suppressed
cell proliferation, whereas H2S donors increased aHSCs proliferation.
Data are presented± SD.
3.4. H2S increases cell metabolic activity
H2S at low concentrations can increase cellular bioenergetics as an
electron donor in mitochondrial oxidative phosphorylation [20,28].
Since enhanced bioenergetics is associated with HSC activation, we
investigated the effect of H2S on the bioenergetics of aHSCs. Two
parameters of cellular metabolic activity, oxygen consumption rate
(OCR) for mitochondrial oxidative phosphorylation and extracellular
acidification rate (ECAR) for glycolysis, were determined using the
Seahorse Extracellular Flux analyzer (Fig. 5). The H2S donors GYY4137
and NaHS increased both the OCR and ECAR and ATP production,
whereas the enzyme inhibitors DL-PAG and AOAA decreased metabolic
activity of HSCs and ATP production.
Effect of H2S donors and enzyme inhibitors on bioenergetics of
aHSCs. Treatments with donors and inhibitors was for 48hrs. OCR and
ECAR are represented as mean ± SEM of a representative experiment
(A, B). Results were normalized with respect to the total amount of
protein. Fold change of normalized maximal and basal level of OCR and
ECAR between conditions were analyzed in 3 different experiments. For
each experiment, every condition was repeated at least two times (C,
D). Production of ATP was calculated using Seahorse XF Cell Mito Stress
Test Report Generator software. Fold change of ATP production in ex-
perimental groups was calculated in 3 independent experiments (E).
3.5. Cth is specifically induced in hepatic stellate cells during fibrogenesis
We next evaluated the expression of H2S synthesizing enzymes in
the bile duct ligation model, an experimental model of chronic in-
flammation leading to fibrosis [29]. mRNA levels of all H2S synthe-
sizing enzymes, Cth, Cbs and Mpst, decreased progressively in the bile
duct ligation model (Fig. 6A–C). As expected, expression of the profi-
brogenic cytokine TGFβ1 increased progressively in the bile duct liga-
tion model (Fig. 6D). We next evaluated the effect of TGFβ1 on the
mRNA expression of H2S synthesizing enzymes in different liver cell
populations. TGFβ1 decreased mRNA expression of all H2S synthesizing
enzymes in hepatocytes. In contrast, TGFβ1 increased mRNA expression
of Cth in HSCs and did not change the mRNA expression of Cbs andMpst
in HSCs (Fig. 6E–G).
Comparison of H2S synthesizing enzymes mRNA levels during fi-
brosis in vivo and in vitro. Cth, Cbs, Mpst were downregulated in total
liver in the BDL model of liver fibrosis (A,B,C). Tgfβ1 expression is
increased in fibrosis (D). 36b4 was used as a housekeeping gene. TGFβ1
reduced the expression of H2S synthesizing enzymes in hepatocytes
(F,G), but it specifically induced Cth mRNA expression in HSCs in vitro
(E).
4. Discussion
The main message of our study is that H2S promotes hepatic stellate
cell activation. This conclusion is based on the fact that production of
H2S and expression its producing enzyme cystathionine γ-lyase (Cth)
expression are increased during hepatic stellate cell activation and on
the fact that exogenous H2S increased HSC proliferation while in-
hibitors of endogenous H2S production reduce proliferation of HSCs.
Although the inhibitors we used are not completely specific for one of
the H2S producing enzymes, e.g. the CBS inhibitor AOAA is also a po-
tent inhibitor of CTH [30] it is important to note that reducing H2S
production leads to reduced stellate cell activation. In addition, since
Fig. 5. H2S increases mitochondrial oxidative phosphorylation and glycolysis in aHSCs.
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CTH is the sole enzyme to upregulated during HSCs activation, it is
likely that the effect of AOAA is mediated via inhibition of CTH.
The effect of H2S on stellate cell activation correlated with increased
cellular bioenergetics. Previous in vivo studies reported that H2S has
anti-fibrotic properties due to its antioxidant and/or anti-inflammatory
actions and its ability to reduce portal hypertension in the liver. In
models of (experimental) fibrosis and cirrhosis, reduced expression of
H2S producing enzymes are observed and an anti-fibrotic effect as well
as reduction of portal hypertension of systemically administered H2S
donors has been reported [7,13–15]. In line with this, in vitro studies,
using the fast-releasing H2S donor NaHS have demonstrated that H2S
inhibits stellate cell proliferation, possibly via decreasing the phos-
phorylation of p38 MAP-Kinase and increasing the phosphorylation of
Akt [9,15]. In another study, the natural H2S donor diallyl trisulfide
suppressed activation of HSCs through cell cycle arrest at the G2/M
checkpoint associated with downregulation of cyclin B1 and cyclin-
dependent kinase 1 in primary rat HSCs [8]. However, the results de-
scribed above were obtained using potentially toxic, fast-releasing H2S
donors, which is not representative of the continuous production of low
levels of H2S by cells. Furthermore, the use of systemically administered
donors or inhibitors does not allow to distinguish effects of H2S on
different cell types present within one organ. Therefore, we applied 2
different H2S releasing donors, GYY4137 and NaHS at concentrations 5
times as lower as in some in vitro studies. Furthermore, most studies
used exogenous H2S donors to study the role of H2S in stellate cell
activation and fibrogenesis and the importance of endogenous pro-
duction of H2S in HSC activation has not been properly addressed.
Therefore, we also used 2 inhibitors of H2S synthesizing enzymes (DL-
PAG and AOAA) and we determined H2S production by HSCs during the
process of activation [8,9].
Our observations of increased expression of H2S synthesizing en-
zyme CTH and increased H2S production during HSC activation in-
dicates a role for H2S in HSC activation and fibrogenesis. Indeed, in-
hibition of endogenous H2S production in HSCs reduced proliferation
and expression of activation markers. These results are in line with the
observation that platelet-derived growth factor BB (PDGF-BB) induced
proliferation of rat mesangial cells via induction of CTH [31] and the
observation that homocysteine, a precursor in H2S synthesis, enhances
activation of rat HSCs via activation of the PI3K/Akt pathway [32]. In
contrast, an anti-fibrotic role has been proposed for cystathionine-β-
synthase (CBS), another PLP-dependent enzyme which is involved in
H2S synthesis in the liver [33,34].
Since our results demonstrated a pro-fibrogenic effect of H2S on
HSCs, whereas most in vivo studies reported an anti-fibrotic role for
H2S, we investigated in more detail the H2S generating capacity in
different liver cell types. First, we determined that expression of H2S-
synthesizing enzymes in hepatocytes and Kupffer cells is much higher
than in HSCs. Next, we determined the expression of H2S-synthesizing
enzymes in the bile duct ligation model of liver fibrosis. We observed a
down-regulation of total hepatic expression of both Cth and Cbs in our
bile duct ligation model. As expected, the pro-fibrogenic cytokine Tgfβ1
was increased in the bile duct ligation model. Finally, we studied the
effect of TGFβ1 on the expression of H2S-synthesizing enzymes in dif-
ferent liver cell types. Of note, we observed that TGFβ1 decreases Cth
and Cbs mRNA expression in hepatocytes, but increased Cth mRNA
expression in stellate cells. These findings could explain the contra-
dictory results between in vivo and in vitro studies with regard to the
role of H2S in fibrogenesis: since hepatocytes are the major source of
H2S in total liver, the increased expression of Tgfβ1 will lead to an
overall reduction in the hepatic expression of Cth and Cbs and H2S
production, whereas at the same time it will increase expression of Cth
and H2S production in hepatic stellate cells. The cell-specific and local
increase in H2S generation also explains the effect of H2S donors and
inhibitors of H2S-synthesizing enzymes on HSC proliferation and acti-
vation. Recently, Szabo et al. reported that a low exogenous dose of H2S
or endogenously produced H2S increases mitochondrial oxidative
phosphorylation [35,36]. In accordance, Katalin et al. described that
low concentrations of H2S stimulates mitochondrial bio-energetics via
S-sulfhydration of ATP- synthase in HepG2 and HEK293 cell lines [20].
Activation of stellate cells is also accompanied by increased bioener-
getics [37]. We have extended these findings by demonstrating that H2S
increases cellular bioenergetics in hepatic stellate cells.
Fig. 6. mRNA expression of Cth, Cbs and Mpst in the bile duct ligation model of liver fibrosis and their regulation by TGFβ1 in different liver cell populations.
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In summary, we demonstrate that stellate cell activation is accom-
panied by increased generation of H2S via induction of the H2S-syn-
thesizing enzyme CTH, leading to increased cellular bioenergetics and
proliferation of HSCs. In addition, the response of H2S-synthesizing
enzymes to the fibrogenic cytokine Tgfβ1 is liver cell-type specific. Our
results indicate that the H2S generation in hepatic stellate cells is a
target for anti-fibrotic intervention and that systemic interventions with
H2S should take into account cell-specific responses to H2S.
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